Attitudes to the prescription of menopause hormone therapy for vasomotor symptoms and osteoporosis for patients of different ages: A survey of gynecologists in Belgium

Serge Rozenberg, Jean Vandromme
Maturitas · 2019 · vol. 128 , pp. 60–63 · doi:10.1016/j.maturitas.2019.07.024 · PMID:31561825 · W2965292665
Observational OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-14 ⓘ

A survey of Belgian gynecologists revealed differing attitudes towards prescribing hormone therapy for vasomotor symptoms and osteoporosis depending on patient age.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

INTRODUCTION: The interpretation of the literature on menopause hormone therapy (MHT) has evolved enormously over the last decade. In recent years, guidelines have reinstated the place of MHT. AIM: This survey analyzes the prescription (initiation and maintenance) of MHT in relation to patient age and therapy indications. MATERIAL AND METHOD: Two vignettes were sent to gynecologists working in Belgium in a random survey. One vignette concerned the initiation of therapy for a woman who was either 52 or 62 years old, suffering either from severe vasomotor symptoms (VSM) or from osteoporosis. The second vignette concerned the maintenance of MHT or switching to another medication in a woman aged 62 years who suffered either from VSM (when stopping MHT) or from osteoporosis. The physicians were asked how they would treat these two patients. RESULTS: We analyzed 443 vignettes from 222 physicians. INITIATION OF MHT: 84% of the respondents would initiate MHT for a 52-year-old woman with VMS, whereas only 32% would do so for a 52-year-old woman who had osteoporosis (chi square = 33; p < 0.001). 51% would initiate MHT for a 62-year-old woman with VMS, whereas only 14% would do so for a 62-year-old woman with osteoporosis (chi square = 17; p < 0.001). MAINTENANCE OF THERAPY: 87% would maintain MHT for a 62-year-old woman with severe VMS and 52% would do so for a 62-year-old woman with osteoporosis (Chi Square 31; p < 0.001). CONCLUSION: VMS are recognized as an indication for MHT, but osteoporosis much less so, even for women around the age of 50.

My notes (saved in your browser only)

MeSH descriptors

Attitude of Health Personnel Gynecology Hormone Replacement Therapy Menopause Osteoporosis, Postmenopausal Age Factors Belgium Female Health Care Surveys Humans Middle Aged Osteoporosis, Postmenopausal

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (17)

Source provenance

openalex
last seen: 2026-05-11T06:12:37.668444+00:00
pubmed
last seen: 2026-10-08T21:25:31.705136+00:00
License: CC0 · commercial use OK